Skip to main navigation Skip to search Skip to main content

Metabophore-mediated retro-metabolic (‘MeMeReMe’) approach in drug design

Research output: Contribution to journalReview articlepeer-review

Abstract

Preclinical toxicity assessments of new drugs require the use of in silico prediction techniques as ethics, cost, time, and complexity limit in vitro and in vivo methods. This review discusses the fundamental concepts of biophores especially toxicophores and their detection methodologies, tools and techniques, as well as ongoing challenges, and methods for overcoming them. This will guide the design community in manipulating lead compounds via a pre-determined pathway based on the MeMeReMe approach. The ideas discussed will be useful both for predicting toxicity and for de-risking leads through optimization.

Original languageEnglish
Article number103736
JournalDrug Discovery Today
Volume28
Issue number10
DOIs
Publication statusPublished - 10-2023

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Metabophore-mediated retro-metabolic (‘MeMeReMe’) approach in drug design'. Together they form a unique fingerprint.

Cite this